Saluda Medical launches voluntary field action for some Evoke system devices

what happened

Saluda Medical said it has started a voluntary field action covering certain Evoke system devices. The step follows the discovery of a low-incidence problem linked to a process change at a third-party manufacturer. According to the company, devices made and shipped after corrective measures were put in place are not affected.

The company said the action is not expected to disrupt product supply or its ability to meet customer demand. Management also does not currently expect a material effect on operations. Saluda Medical is working with the U.S. FDA and other regulators on how the action should be classified.

why it matters

This is a company-specific update covering a narrow medical device segment. It is unlikely to move broader markets, and the company expects no material change to its operations.

tags